| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Christina Voulgari, Raphael Giannas, Georgios Paterakis, Anna Kanellou, Nikolaos Anagnostopoulos, Stamata Pagon. Clozapine-Induced Late Agranulocytosis and Severe Neutropenia Complicated with Streptococcus pneumonia, Venous Thromboembolism, and Allergic Vasculitis in Treatment-Resistant Female Psychosis. Case reports in medicine. vol 2015. 2015-03-10. PMID:25755670. |
clozapine is a second-generation antipsychotic agent from the benzodiazepine group indicated for treatment-resistant schizophrenia and other psychotic conditions. |
2015-03-10 |
2023-08-13 |
Not clear |
| Aaron Jenkins, José A Apud, Fengyu Zhang, Heather Decot, Daniel R Weinberger, Amanda J La. Identification of candidate single-nucleotide polymorphisms in NRXN1 related to antipsychotic treatment response in patients with schizophrenia. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 39. issue 9. 2015-03-02. PMID:24633560. |
based on previous suggestive evidence of an impact on clozapine response in patients with schizophrenia, we conducted an association study of nrxn1 polymorphisms (rs12467557 and rs10490162) with antipsychotic treatment response in 54 patients with schizophrenia in a double blind, placebo-controlled nimh inpatient crossover trial and examined for association with risk for schizophrenia in independent case-control and family-based clinical cohorts. |
2015-03-02 |
2023-08-12 |
Not clear |
| Cuiping Yang, Changchun Cai, Xiaojin Yang, Yanping Yang, Zhigang Zhou, Jianhua Liu, Heping Ye, Hongjiao Wa. Wendan decoction improves learning and memory deficits in a rat model of schizophrenia. Neural regeneration research. vol 7. issue 15. 2015-02-27. PMID:25722705. |
the results revealed that the latency of schizophrenia model rats to escape from the hidden platform in the morris water maze was significantly shortened after administration of wendan decoction or clozapine. |
2015-02-27 |
2023-08-13 |
rat |
| Marcos Leite Santoro, Vanessa Kiyomi Ota, Roberta Sessa Stilhano, Patrícia Natália Silva, Camila Maurício Santos, Mariana Cepollaro Diana, Ary Gadelha, Rodrigo Affonseca Bressan, Maria Isabel Melaragno, Sang Won Han, Vanessa Costhek Abílio, Sintia Iole Belanger. Effect of antipsychotic drugs on gene expression in the prefrontal cortex and nucleus accumbens in the spontaneously hypertensive rat (SHR). Schizophrenia research. vol 157. issue 1-3. 2015-02-26. PMID:24893910. |
each group was treated with a different apd (risperidone, clozapine or haloperidol), and with a non-treated group of spontaneously hypertensive rats (shrs), which is an animal model for schizophrenia. |
2015-02-26 |
2023-08-13 |
rat |
| Jimmy Lee, Valerie Powell, Gary Remingto. Mean platelet volume in schizophrenia unaltered after 1year of clozapine exposure. Schizophrenia research. vol 157. issue 1-3. 2015-02-26. PMID:24906221. |
mean platelet volume in schizophrenia unaltered after 1year of clozapine exposure. |
2015-02-26 |
2023-08-13 |
Not clear |
| Jimmy Lee, Valerie Powell, Gary Remingto. Mean platelet volume in schizophrenia unaltered after 1year of clozapine exposure. Schizophrenia research. vol 157. issue 1-3. 2015-02-26. PMID:24906221. |
we found high mpv in patients with schizophrenia and related psychoses, which was unaltered after 1year of clozapine treatment. |
2015-02-26 |
2023-08-13 |
Not clear |
| S Gee, F Vergunst, O Howes, D Taylo. Practitioner attitudes to clozapine initiation. Acta psychiatrica Scandinavica. vol 130. issue 1. 2015-02-12. PMID:24004162. |
clozapine is the most effective antipsychotic for treatment-resistant schizophrenia. |
2015-02-12 |
2023-08-12 |
Not clear |
| M C Davis, M A Fuller, M E Strauss, P E Konicki, G E Jaski. Discontinuation of clozapine: a 15-year naturalistic retrospective study of 320 patients. Acta psychiatrica Scandinavica. vol 130. issue 1. 2015-02-12. PMID:24299466. |
clozapine is underutilized in the management of treatment-resistant schizophrenia. |
2015-02-12 |
2023-08-12 |
Not clear |
| P Ifteni, J Nielsen, V Burtea, C U Correll, J M Kane, P Man. Effectiveness and safety of rapid clozapine titration in schizophrenia. Acta psychiatrica Scandinavica. vol 130. issue 1. 2015-02-12. PMID:24354448. |
effectiveness and safety of rapid clozapine titration in schizophrenia. |
2015-02-12 |
2023-08-12 |
Not clear |
| P F J Schulte, D van Dijk, D Cohen, J Bogers, B Bakke. Comment on 'effectiveness and safety of rapid clozapine titration in schizophrenia'. Acta psychiatrica Scandinavica. vol 130. issue 1. 2015-02-12. PMID:24689810. |
comment on 'effectiveness and safety of rapid clozapine titration in schizophrenia'. |
2015-02-12 |
2023-08-12 |
Not clear |
| Antonios Paraschaki. Pipamperone augmentation of clozapine and sodium valproate in refractory schizophrenia: a case report. Clinical neuropharmacology. vol 37. issue 2. 2015-02-04. PMID:24614672. |
pipamperone augmentation of clozapine and sodium valproate in refractory schizophrenia: a case report. |
2015-02-04 |
2023-08-12 |
Not clear |
| Antonios Paraschaki. Pipamperone augmentation of clozapine and sodium valproate in refractory schizophrenia: a case report. Clinical neuropharmacology. vol 37. issue 2. 2015-02-04. PMID:24614672. |
clozapine is currently considered as the most effective medication for the treatment of refractory schizophrenia. |
2015-02-04 |
2023-08-12 |
Not clear |
| Antonios Paraschaki. Pipamperone augmentation of clozapine and sodium valproate in refractory schizophrenia: a case report. Clinical neuropharmacology. vol 37. issue 2. 2015-02-04. PMID:24614672. |
we present a case of a 37-year-old patient with refractory schizophrenia who has responded well to the combination of clozapine, sodium valproate, and pipamperone. |
2015-02-04 |
2023-08-12 |
Not clear |
| Ravi Parekh, Zozik Fattah, Dilraj Sahota, Bernie Colac. Clozapine induced tubulointerstitial nephritis in a patient with paranoid schizophrenia. BMJ case reports. vol 2014. 2015-01-28. PMID:24849641. |
clozapine induced tubulointerstitial nephritis in a patient with paranoid schizophrenia. |
2015-01-28 |
2023-08-13 |
Not clear |
| Ravi Parekh, Zozik Fattah, Dilraj Sahota, Bernie Colac. Clozapine induced tubulointerstitial nephritis in a patient with paranoid schizophrenia. BMJ case reports. vol 2014. 2015-01-28. PMID:24849641. |
we describe the development of tubulointerstitial nephritis after starting clozapine therapy in a patient with treatment-resistant schizophrenia. |
2015-01-28 |
2023-08-13 |
Not clear |
| Ravi Parekh, Zozik Fattah, Dilraj Sahota, Bernie Colac. Clozapine induced tubulointerstitial nephritis in a patient with paranoid schizophrenia. BMJ case reports. vol 2014. 2015-01-28. PMID:24849641. |
a 54-year-old mixed-race patient with a longstanding history of paranoid schizophrenia was started on the antipsychotic clozapine. |
2015-01-28 |
2023-08-13 |
Not clear |
| De-Wei Shang, Li-Jun Li, Xi-Pei Wang, Yu-Guan Wen, Yu-Peng Ren, Wei Guo, Wen-Biao Li, Liang Li, Tian-Yan Zhou, Wei Lu, Chuan-Yue Wan. Population pharmacokinetic/pharmacodynamic model of clozapine for characterizing the relationship between accumulated exposure and PANSS scores in patients with schizophrenia. Therapeutic drug monitoring. vol 36. issue 3. 2015-01-12. PMID:24342896. |
population pharmacokinetic/pharmacodynamic model of clozapine for characterizing the relationship between accumulated exposure and panss scores in patients with schizophrenia. |
2015-01-12 |
2023-08-12 |
Not clear |
| De-Wei Shang, Li-Jun Li, Xi-Pei Wang, Yu-Guan Wen, Yu-Peng Ren, Wei Guo, Wen-Biao Li, Liang Li, Tian-Yan Zhou, Wei Lu, Chuan-Yue Wan. Population pharmacokinetic/pharmacodynamic model of clozapine for characterizing the relationship between accumulated exposure and PANSS scores in patients with schizophrenia. Therapeutic drug monitoring. vol 36. issue 3. 2015-01-12. PMID:24342896. |
the aim of this study was to characterize the relationship between accumulated exposure of clozapine and changes in positive and negative syndrome scale (panss) score in chinese patients with schizophrenia by pharmacokinetic/pharmacodynamic (pk/pd) modeling. |
2015-01-12 |
2023-08-12 |
Not clear |
| Seon-Cheol Park, Myung-Soo Lee, Seung-Gul Kang, Seung-Hwan Le. Patterns of antipsychotic prescription to patients with schizophrenia in Korea: results from the health insurance review & assessment service-national patient sample. Journal of Korean medical science. vol 29. issue 5. 2015-01-10. PMID:24851031. |
in this study, it has been reported substantial prescription rates of first-generation antipsychotics and antipsychotic polypharmacy and relatively small prescription rate of clozapine to patients with schizophrenia. |
2015-01-10 |
2023-08-13 |
Not clear |
| M Gahr, K Rehbaum, B J Conneman. Clozapine-associated development of second-onset obsessive compulsive symptoms in schizophrenia: impact of clozapine serum levels and fluvoxamine add-on. Pharmacopsychiatry. vol 47. issue 3. 2015-01-07. PMID:24846087. |
clozapine-associated development of second-onset obsessive compulsive symptoms in schizophrenia: impact of clozapine serum levels and fluvoxamine add-on. |
2015-01-07 |
2023-08-13 |
Not clear |